(b)(4).Investigation summary: the review did not reveal any detected quality issues during the production process that could have contributed to this reported incident.To aid in the investigation of this incident, one photo was provided.It shows a packaging blister top web however, it does not show the symptom and product reported.As a sample was unavailable for return, a thorough sample investigation could not be completed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Investigation conclusion: unconfirmed: bd was not able to duplicate or confirm the customer¿s indicated failure with the photo provided.Root cause description: based on the investigation results, an exact cause for this incident could not be identified.Rationale: further action has not been determined necessary at this time.Our quality team will continue to monitor the manufacturing process for this defect and other emerging trends.
|
It was reported that there were no scale markings on the syringe oral 50ml clear sterile.The following information was provided by the initial reporter: "it was reported that the markings on syringe are missing." date: (b)(6) 2020 at 3 pm, harm: no harm, department: nicu/supply chain, reported by: rn, product description: bd 50 ml oral/enteral syringe.Enternal feeding syringe utilized in the nicu.
|